Mechanism of action
Copper(II) sulfate acts primarily through chemical complexation and oxidation reactions rather than receptor-mediated pharmacology.
Antidote mechanism
In phosphorus poisoning, copper sulfate forms insoluble copper phosphide complexes in the gastrointestinal tract. These complexes prevent absorption of elemental phosphorus, which would otherwise cause severe systemic toxicity including hepatotoxicity and cardiovascular collapse. The copper ions oxidize phosphorus, converting it to less toxic forms.
Emetic mechanism
Copper sulfate causes direct irritation of the gastric mucosa, triggering the vomiting reflex through local irritant effects. This mechanism is non-selective and can cause significant mucosal damage.
Biochemical role
As a trace element, copper serves as a cofactor for numerous enzymes including cytochrome c oxidase, superoxide dismutase, and ceruloplasmin. Copper is essential for iron metabolism, connective tissue synthesis, and neurotransmitter production. However, excess copper is toxic due to oxidative stress generation.
- Copper sulfate forms insoluble copper phosphide complexes, preventing phosphorus absorption in elemental phosphorus poisoning
- Classic triad of copper sulfate toxicity: blue-green vomitus, hemorrhagic gastroenteritis, followed by hepatotoxicity and hemolytic anemia
- Fatal dose of copper sulfate is 10-20 grams; gastrointestinal corrosion occurs at lower doses
- Zinc competitively inhibits copper absorption at intestinal transporters (most significant drug interaction)
- Penicillamine is the antidote for copper toxicity; acts as a copper chelator
- Copper sulfate is absolutely contraindicated in Wilson disease (genetic copper overload disorder)
- Use as an emetic is obsolete due to severe corrosive toxicity and availability of safer alternatives
- Copper is primarily eliminated via bile (95%); renal excretion is minimal, but hemoglobinuria from hemolysis causes acute kidney injury
Indications
Copper(II) sulfate has limited modern clinical indications due to its toxicity profile.
Current uses
- Phosphorus poisoning: Antidote for elemental (white or yellow) phosphorus ingestion, typically from rodenticides or fireworks
- Copper deficiency: Rare use as copper supplement in severe deficiency states, though safer organic copper compounds are preferred
- Hypocupremia in total parenteral nutrition: Trace element supplementation
Historical uses (largely abandoned)
- Emetic agent for poisoning (replaced by activated charcoal and gastric lavage)
- Topical antiseptic (too irritating for routine use)
- Fungicide and algicide (agricultural/industrial only)
Off-label considerations
Copper sulfate has no significant off-label medical uses due to its narrow therapeutic index and availability of safer alternatives.
Pharmacokinetics
Copper sulfate pharmacokinetics are complex and dose-dependent.
Absorption: Highly variable oral absorption (12-60%) depending on copper status and dietary factors. Absorption occurs primarily in the duodenum and proximal jejunum via specific copper transporters (CTR1). Acidic pH enhances absorption.
Distribution: Absorbed copper binds rapidly to albumin and transcuprein in plasma. Copper accumulates in liver (primary storage organ), brain, kidneys, and heart. Crosses placenta and enters breast milk. Does not significantly cross blood-brain barrier under normal conditions.
Metabolism: Copper undergoes minimal metabolism but is incorporated into cuproenzymes and ceruloplasmin in the liver. Excess copper is bound to metallothionein for storage or biliary excretion.
Excretion: Primary route is biliary elimination into feces (95%). Minimal renal excretion (2-4%). Biliary copper is not significantly reabsorbed. Half-life varies with copper status but is approximately 13-33 days for total body copper stores.
Special populations: Absorption increases in copper deficiency and decreases in copper overload states. Patients with Wilson disease have impaired biliary copper excretion.
Adverse effects
Copper(II) sulfate has a narrow therapeutic index with significant toxicity.
Gastrointestinal effects (most common)
- Nausea and vomiting (dose-dependent)
- Severe abdominal pain and cramping
- Hemorrhagic gastroenteritis
- Mucosal corrosion and ulceration
- Blue-green vomitus (pathognomonic for copper ingestion)
- Diarrhea, sometimes bloody
- Metallic taste
Systemic toxicity (dose-related)
- Hepatotoxicity: Acute hepatic necrosis with elevated transaminases, jaundice, coagulopathy
- Hematologic: Intravascular hemolysis with hemoglobinuria, methemoglobinemia, hemolytic anemia
- Renal: Acute tubular necrosis, acute kidney injury from hemoglobinuria
- Cardiovascular: Hypotension, cardiovascular collapse in severe poisoning
- Metabolic: Metabolic acidosis
Neurologic effects
- Seizures (severe toxicity)
- Altered mental status
- Coma (with massive overdose)
Chronic exposure
- Wilson disease-like syndrome (rare)
- Hepatic cirrhosis
- Neurologic deterioration
Fatal dose: 10-20 grams of copper sulfate can be lethal in adults. Fatalities have occurred with ingestion of as little as 1 gram.
Contraindications and warnings
Absolute contraindications
- Wilson disease (copper overload disorder)
- Known hypersensitivity to copper compounds
- Hemolytic anemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Active gastrointestinal bleeding or peptic ulcer disease
- Severe hepatic impairment
- Use as an emetic (no longer recommended due to toxicity)
Relative contraindications
- Renal impairment (reduced copper clearance)
- Pregnancy (teratogenic potential in high doses)
- Pediatric use (increased susceptibility to toxicity)
Warnings and precautions
Black box equivalent considerations: Although copper sulfate lacks formal black box warnings due to limited FDA-approved indications, it would warrant such warnings for severe gastrointestinal corrosion, hepatotoxicity, and hemolysis risk.
Hepatic monitoring: Liver function tests should be monitored during treatment for phosphorus poisoning.
Hematologic monitoring: Complete blood count and signs of hemolysis (hemoglobinuria, decreased haptoglobin) require monitoring.
Pregnancy: Category C equivalent. Copper crosses the placenta. Use only if benefit clearly outweighs risk. High doses are teratogenic in animal studies.
Lactation: Copper is excreted in breast milk. Monitor infant copper status if maternal treatment is necessary.
Pediatric: Children are more susceptible to copper toxicity. Use only when absolutely necessary with careful dose adjustment.
Drug interactions
Copper sulfate has primarily pharmacokinetic interactions affecting absorption.
Decreased copper absorption
- Zinc supplements: Competitive inhibition of copper absorption at intestinal transporters (most clinically significant interaction)
- Iron supplements: Competition for absorption, though less pronounced than zinc
- Antacids: Increased gastric pH reduces copper absorption
- Proton pump inhibitors and H2 blockers: Decreased absorption due to reduced gastric acidity
- Calcium supplements: May interfere with copper uptake
- High-dose vitamin C: Forms complexes reducing absorption
- Phytates and fiber: Dietary components that chelate copper
Increased copper absorption or toxicity
- Acidic beverages: Enhanced copper dissolution and absorption
- Penicillamine: Although a copper chelator for Wilson disease, acute co-administration may mobilize tissue copper stores
Pharmacodynamic interactions
- Hemolytic agents: Additive risk of hemolysis (antimalarials, sulfonamides in G6PD deficiency)
- Hepatotoxic drugs: Additive liver toxicity risk
- Nephrotoxic agents: Increased acute kidney injury risk
Laboratory interactions
Copper sulfate may interfere with serum copper and ceruloplasmin measurements. Hemolysis from copper toxicity can cause falsely elevated potassium and lactate dehydrogenase levels.
Clinical pearls
- Classic presentation of copper sulfate poisoning: Blue-green vomitus, hemorrhagic gastroenteritis, followed by hepatotoxicity and hemolytic anemia 1-3 days post-ingestion.
- Phosphorus poisoning triad: "Smoking stool syndrome" (phosphorescent feces), garlic breath odor, and "phossy jaw" (chronic exposure). Copper sulfate prevents absorption when given early.
- Chelation therapy: For severe copper toxicity, chelation with penicillamine or dimercaprol (BAL) may be necessary. Hemodialysis does not effectively remove copper but may be needed for acute kidney injury.
- Serum copper levels: Normal range 70-140 mcg/dL. Levels >200 mcg/dL suggest toxicity. Free (non-ceruloplasmin-bound) copper is more toxic.
- Exam tip: Copper sulfate as an emetic is obsolete. If a question describes its use for inducing vomiting, the answer is likely that it should NOT be used due to corrosive toxicity.
- Wilson disease screening: In suspected copper poisoning, check ceruloplasmin, 24-hour urinary copper, and slit-lamp exam for Kayser-Fleischer rings to rule out underlying copper metabolism disorder before any copper administration.
- Antidote for copper poisoning: Penicillamine is first-line. British anti-Lewisite (BAL) is second-line. Supportive care for hemolysis and hepatotoxicity is essential.
- Agricultural vs medical: Most copper sulfate exposures are accidental ingestions of agricultural/industrial products. Medical-grade copper sulfate is rarely encountered outside of specialized toxicology settings.
- Hemodialysis consideration: While copper is not dialyzable, dialysis may be needed for severe acute kidney injury from hemoglobinuria.
- Chronic toxicity mimics Wilson disease: Both present with hepatic cirrhosis, neurologic symptoms, and Kayser-Fleischer rings, but Wilson disease has low ceruloplasmin while exogenous copper toxicity has normal or high ceruloplasmin.
Practice questions
1. A 24-year-old man is brought to the emergency department 2 hours after ingesting an algaecide in a suicide attempt. He reports severe abdominal pain and has vomited twice; the vomitus has a distinctive blue-green color. Vital signs show blood pressure 95/60 mmHg, heart rate 118/min, and temperature 37.2°C (99°F). Laboratory studies show AST 845 U/L, ALT 920 U/L, and presence of hemoglobinuria. Which substance was most likely ingested?
2. A 6-year-old girl accidentally ingests elemental phosphorus from fireworks. Her parents bring her to the emergency department within 30 minutes of ingestion. She is alert and has not vomited. Physical examination is unremarkable. Which of the following treatments should be administered to prevent phosphorus absorption?
3. A 45-year-old man with Wilson disease is evaluated for new-onset tremor and behavioral changes. His sister mentions he has been taking a "blue powder supplement" he purchased online for energy. Laboratory studies show serum copper 280 mcg/dL (normal 70-140), ceruloplasmin 8 mg/dL (normal 20-40), AST 156 U/L, and ALT 198 U/L. Slit-lamp examination reveals Kayser-Fleischer rings. What is the most appropriate immediate management?
Frequently asked questions
How does copper sulfate work as an antidote?
Copper sulfate works by forming insoluble copper phosphide complexes in the gastrointestinal tract when elemental phosphorus is ingested. These complexes prevent the absorption of toxic phosphorus into the bloodstream. The copper ions oxidize phosphorus to less toxic forms, reducing systemic exposure. This mechanism is specifically useful in poisoning from white or yellow phosphorus found in rodenticides and fireworks. However, copper sulfate itself has significant toxicity and must be used cautiously under medical supervision.
What are the side effects of copper sulfate?
Copper sulfate causes severe gastrointestinal effects including nausea, vomiting with characteristic blue-green color, abdominal pain, and hemorrhagic gastroenteritis with mucosal corrosion. Systemic toxicity includes acute hepatic necrosis with elevated liver enzymes, intravascular hemolysis leading to hemoglobinuria, acute kidney injury from tubular necrosis, and potentially cardiovascular collapse. Hematologic effects include hemolytic anemia and methemoglobinemia. Fatal poisoning can occur with ingestion of 10-20 grams, and toxicity develops at lower doses. The narrow therapeutic index makes copper sulfate inherently dangerous.
Is copper sulfate still used medically?
Copper sulfate has very limited modern medical use due to its significant toxicity and narrow therapeutic index. Its primary remaining indication is as an antidote for acute elemental phosphorus poisoning, though even this use is rare. It may occasionally be used as a copper supplement in severe copper deficiency or in total parenteral nutrition, but safer organic copper compounds are preferred. Its historical use as an emetic has been completely abandoned because the risk of gastrointestinal corrosion and systemic toxicity outweighs any benefit, and safer alternatives like activated charcoal are now standard.
What is the antidote for copper sulfate poisoning?
The primary antidote for copper sulfate poisoning is penicillamine, which acts as a copper chelator by binding free copper ions and promoting their urinary excretion. Dimercaprol (British anti-Lewisite or BAL) is a second-line chelating agent if penicillamine is unavailable or not tolerated. Treatment also requires aggressive supportive care including fluid resuscitation, correction of metabolic acidosis, management of hemolytic anemia, and monitoring for acute liver and kidney injury. Hemodialysis may be necessary for severe acute kidney injury from hemoglobinuria, though it does not directly remove copper.
Copper sulfate vs zinc sulfate — what is the difference?
Copper sulfate and zinc sulfate are both inorganic metal salts but have different clinical uses and toxicity profiles. Copper sulfate is primarily used as an antidote for phosphorus poisoning and has severe gastrointestinal and systemic toxicity including hepatotoxicity and hemolysis. Zinc sulfate is used for zinc supplementation and as an emetic (also largely obsolete), with milder toxicity causing mainly gastrointestinal upset. Importantly, zinc and copper compete for intestinal absorption, so high-dose zinc supplementation can induce copper deficiency, and vice versa. This competitive inhibition is the most clinically significant interaction between the two compounds.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: V03AB20
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.